Helius Medical Technologies (HSM) Stock Price, News & Analysis

Company Overview

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Key Stats

• Today's Range: C$18.35 to C$18.48
• 50-Day Range: C$18.35 to C$18.35
• 52-Week Range: C$14.26 to C$40.00
• Volume: 930 shs
• Average Volume: 3,578 shs
• Market Capitalization: C$42.54 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HSM Stock Analysis - Frequently Asked Questions

How have HSM shares performed this year?

Helius Medical Technologies' stock was trading at C$18.35 at the beginning of the year. Since then, HSM shares have increased by 0.0% and is now trading at C$18.35.
View the best growth stocks for 2024 here.

How do I buy shares of Helius Medical Technologies?

Shares of HSM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Helius Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Helius Medical Technologies investors own include Athabasca Oil (ATH), VanEck Junior Gold Miners ETF (GDXJ), Suncor Energy (SU), Teck Resources (TECK.B), Whitecap Resources (WCP), Air Canada (AC) and Black Iron (BKI).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: TSE:HSM
• CUSIP: N/A
• CIK: N/A
• Web: heliusmedical.com
• Phone: 215-944-6100
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 152.92
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.74
• Current Ratio: 4.20
• Quick Ratio: 3.58

Sales & Book Value

• Annual Sales: C$477,000.00
• Price / Sales: 89.17
• Cash Flow: C$3.21 per share
• Price / Cash Flow: 5.71
• Book Value: C$3.61 per share
• Price / Book: 5.08

Miscellaneous

• Outstanding Shares: 2,318,000
• Free Float: N/A
• Market Cap: C$42.54 million
• Optionable: Not Optionable
• Beta: N/A